Menu
 
Research menu
Jump to menu

Publications:  Dr Radha Gadhok

Gadhok R, Gordon H, Sebepos-Rogers G, Baillie S, Akbar S, Abbott JE, Michael E, Ahmad OF et al.(2020). UK Patients of Bangladeshi Descent with Crohn’s Disease Respond Less Well to TNF Antagonists Than Caucasian Patients. Digestive Diseases and Sciences vol. 65, (6) 1790-1799.
10.1007/s10620-019-05907-w
Honap S, Gadhok R, Rao R, Samaan MA, Harpham-Lockyer L, Kwok H, Whitley L, Ibarra A et al. (2019). USTEKINUMAB: EARLY EXPERIENCE AND MEDIUM-TERM OUTCOMES FROM A UK MULTI-CENTRE REAL-WORLD COHORT. GASTROENTEROLOGY. vol. 156, S885-S886.
Rao R, Gadhok R, Whitley L, Burgess N, Amon P, Naik S, Lindsay J, McCartney S et al. (2019). Ustekinumab for refractory paediatric Crohn's disease: experience from two UK tertiary referral centres. JOURNAL OF CROHNS & COLITIS. vol. 13, S424-S425.
10.1093/ecco-jcc/jjy222.740
Gadhok R, Rao R, Honap S, Samaan M, Harpham-Lockyer L, Kwok H, Whitley L, Ibarra A et al. (2019). Ustekinumab: early experience and mediumterm outcomes from a UK multi-centre realworld cohort. JOURNAL OF CROHNS & COLITIS. vol. 13, S260-S260.
10.1093/ecco-jcc/jjy222.442
Sebepos-Rogers G, Jayasooriya N, Gadhok R, Gordon H, O'Donnell S (2018). ANTI-DRUG ANTIBODIES TO ANTI-TNFS: EXPERIENCE AND OUTCOMES AT A TERTIARY IBD CENTRE. GUT. vol. 67, A92-A93.
10.1136/gutjnl-2018-BSGAbstracts.182
Gordon H, Gadhok R, Ibarra A, Lindsay JO (2018). UK Asians are prescribed vedolizumab earlier in disease history than Caucasians, but respond equally well to therapy. JOURNAL OF CROHNS & COLITIS. vol. 12, S459-S459.
Gadhok R, Gordon H, Sebepos-Rogers G, Baillie S, Akbar S, Ahmad OF, Cooper B, Lindsay JO (2017). ANTI-TNFS MORE FREQUENTLY STOPPED DUE TO LOSS OF RESPONSE IN BRITISH ASIANS WITH CROHN'S DISEASE: A SINGLE CENTRE RETROSPECTIVE ANALYSIS. GUT. vol. 66, A255-A255.
10.1136/gutjnl-2017-314472.497
Gordon H, Gadhok R, Sebepos-Rogers G, Baillie S, Akbar S, Ahmad OF, Cooper BE, Lindsay JO (2017). ANTI-TNFS MORE FREQUENTLY STOPPED DUE TO LOSS OF RESPONSE IN BRITISH ASIANS WITH CROHN'S DISEASE: A SINGLE CENTRE RETROSPECTIVE ANALYSIS. GASTROENTEROLOGY. vol. 152, S363-S363.
10.1016/S0016-5085(17)31468-3
Gadhok R, Gordon H, Sebepos-Rogers G, Baillie S, Akbar S, Ahmad OF, Cooper B, Lindsay JO (2017). Anti-TNFs more frequently stopped due to loss of response in British Asians with Crohn's disease: a single centre retrospective analysis. JOURNAL OF CROHNS & COLITIS. vol. 11, S393-S393.
Gadhok R, Murray S, Wood E (2016). VIRTUAL REALITY AND BEYOND: INTEGRATING SIMULATION INTO THE GASTROENTEROLOGY TRAINING CURRICULUM. GUT. vol. 65, A281-A282.
10.1136/gutjnl-2016-312388.529
Hall H, Gadhok R, Alshafi K, Bilton D, Simmonds NJ(2015). Eradication of respiratory tract MRSA at a large adult cystic fibrosis centre. Respiratory Medicine vol. 109, (3) 357-363.
10.1016/j.rmed.2015.01.013
Green H, Gadhok R, Alshafi K, Bilton D, Simmonds NJ (2013). SUCCESSFUL ERADICATION OF RESPIRATORY TRACT MRSA IN CYSTIC FIBROSIS: A RETROSPECTIVE STUDY. THORAX. vol. 68, A120-A120.
10.1136/thoraxjnl-2013-204457.250
Green H, Gadhok R, Alshafi K, Bilton D, Simmonds N (2013). A RETROSPECTIVE STUDY OF RESPIRATORY TRACT MRSA ERADICATION AT A LARGE ADULT CYSTIC FIBROSIS UNIT. PEDIATRIC PULMONOLOGY. vol. 48, 320-320.
Antoniades C, Triantafyllou E, Gadhok R, Abeles R, Quaglia A, Khamri W, Tidswell R, McPhail M et al. (2013). CD163 IS A MECHANISTIC BIOMARKER IN ACUTE LIVER FAILURE REFLECTING A MACROPHAGE ACTIVATION LIKE SYNDROME. JOURNAL OF HEPATOLOGY. vol. 58, S417-S417.
10.1016/S0168-8278(13)61015-6
Possamai L, McPhail M, Quaglia A, Abeles R, Tidswell R, Gadhok R, Khamri W, Zingarelli V et al. (2013). CHARACTER AND TEMPORAL EVOLUTION OF APOPTOSIS IN ACETAMINOPHEN-INDUCED ACUTE LIVER FAILURE. JOURNAL OF HEPATOLOGY. vol. 58, S415-S416.
10.1016/S0168-8278(13)61010-7
Tidswell R, Gadhok R, Vergis N, McPhail MJ, Selvapatt N, Vijay GKM, Quaglia A, Bernal W et al. (2013). DEFECTIVE MONOCYTE PHAGOCYTOSIS MAY EXPLAIN SUSCEPTIBILITY TO SEPSIS AND BE A TARGET FOR IMMUNOTHERAPY IN ACUTE-ON-CHRONIC LIVER FAILURE. JOURNAL OF HEPATOLOGY. vol. 58, S248-S248.
10.1016/S0168-8278(13)60609-1
Russell GK, Gadhok R, Simmonds NJ(2013). The destructive combination of Scediosporium apiosperum lung disease and exuberant inflammation in cystic fibrosis. Paediatric Respiratory Reviews vol. 14, (SUPPL.1) 22-25.
10.1016/j.prrv.2013.02.004
Dickson JL, Gadhok R, Hind MD, Simonds AK, Polkey MI (2012). CPR AND VENTILATION PREFERENCES IN COPD PATIENTS USING HOME NIV: STILL UNEXPLORED AFTER TEN YEARS. THORAX. vol. 67, A165-A166.
10.1136/thoraxjnl-2012-202678.292
Roberts CH, Smith C, Breen R, Gadhok R, Murphy M, Aryee A, Cropley I, Bhagani S et al.(2011). Hepatotoxicity in the treatment of tuberculosis using moxifl oxacincontaining regimens. International Journal of Tuberculosis and Lung Disease vol. 15, (9) 1275-1276.
10.5588/ijtld.11.0352
Roberts CH, Gadhok R, Breen R, Murphy M, Smith C, Cropley I, Bhagani S, Hopkins S et al. (2009). SAFETY OF MOXIFLOXACIN WHEN USED TO TREAT ACTIVE TUBERCULOSIS IN PATIENTS AT RISK OF HEPATOTOXICITY. THORAX. vol. 64, A123-A124.
10.1136/thx.2009.127167k
Return to top